Literature DB >> 16962062

Identification, sequencing and expression of peroxidoxin genes from Leishmania aethiopica.

Dagim Jirata1, Teklu Kuru, Abebe Genetu, Stephen Barr, Asrat Hailu, Abraham Aseffa, Lashitew Gedamu.   

Abstract

Cutaneous leishmaniasis (CL) is a painful, disfiguring and debilitating disease prevalent in Ethiopia and other countries around the world. In Ethiopia, CL is primarily caused by Leishmania aethiopica and less often by L. tropica and L. major. The intracellular survival mechanisms of Leishmania parasites are still not well understood. Recently a new family of antioxidant enzymes called peroxidoxins have been identified that play an important role in parasite survival. In this study, we have identified two distinct peroxidoxin genes (Pxn1 and Pxn2) that are part of a multi-gene family in L. aethiopica. Protein sequence analysis showed that Pxn1 and Pxn2 are highly homologous to peroxidoxins from other Leishmania species. We have found that L. aethiopica Pxn1 is predominantly expressed in amastigotes and stationary phase promastigotes, whereas Pxn2 is constitutively expressed in the different stages of the parasite. This pattern of RNA expression is consistent with patterns seen in some Leishmania species, but not all. Data from this study will be helpful in enhancing vaccine strategies and drug studies targeted towards peroxidoxins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962062     DOI: 10.1016/j.actatropica.2006.08.001

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Leishmania mexicana amazonensis: plasma membrane adenine nucleotide translocator and chemotaxis.

Authors:  S Detke; R Elsabrouty
Journal:  Exp Parasitol       Date:  2007-10-22       Impact factor: 2.011

3.  A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major.

Authors:  Janine König; Alan H Fairlamb
Journal:  FEBS J       Date:  2007-10-08       Impact factor: 5.542

4.  DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant.

Authors:  Abebe Genetu Bayih; Nada S Daifalla; Lashitew Gedamu
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

5.  Anti-mitochondrial Tryparedoxin Peroxidase Monoclonal Antibody-Based Immunohistochemistry for Diagnosis of Cutaneous Leishmaniasis.

Authors:  Mariana Lourenço Freire; Felipe Dutra Rego; Karine Ferreira Lopes; Lucélia Antunes Coutinho; Rafaella Fortini Queiroz Grenfell; Daniel Moreira Avelar; Gláucia Cota; Marcelo Antônio Pascoal-Xavier; Edward Oliveira
Journal:  Front Microbiol       Date:  2022-02-28       Impact factor: 5.640

6.  Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence.

Authors:  Calvin A Henard; Eric D Carlsen; Christie Hay; Peter E Kima; Lynn Soong
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17

7.  Evaluation of the CL Detect Rapid Test in Ethiopian patients suspected for Cutaneous Leishmaniasis.

Authors:  Saskia van Henten; Helina Fikre; Roma Melkamu; Dilargachew Dessie; Tigist Mekonnen; Mekibib Kassa; Tadfe Bogale; Rezika Mohammed; Lieselotte Cnops; Florian Vogt; Myrthe Pareyn; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2022-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.